232 related articles for article (PubMed ID: 16758523)
41. Atypical antipsychotics in the treatment of posttraumatic stress disorder.
Wang HR; Woo YS; Bahk WM
Clin Neuropharmacol; 2013; 36(6):216-22. PubMed ID: 24201234
[TBL] [Abstract][Full Text] [Related]
42. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
43. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
44. Correlates of Nonimprovement to Pharmacotherapy for Chronic, Antidepressant-Resistant, Military Service-Related Posttraumatic Stress Disorder: Insights From the Veterans Affairs Cooperative Study No. 504.
Byrne SP; Krystal JH; Rosenheck RA; Vessicchio J; Pietrzak RH;
J Clin Psychopharmacol; 2017 Dec; 37(6):717-721. PubMed ID: 28945664
[TBL] [Abstract][Full Text] [Related]
45. Metabolic syndrome and combat post-traumatic stress disorder intensity: preliminary findings.
Babić D; Jakovljević M; Martinac M; Sarić M; Topić R; Maslov B
Psychiatr Danub; 2007 Jun; 19(1-2):68-75. PubMed ID: 17603419
[TBL] [Abstract][Full Text] [Related]
46. Medication adherence and its effect on relapse among patients discharged from a Veterans Affairs posttraumatic stress disorder treatment program.
Lockwood A; Steinke DT; Botts SR
Ann Pharmacother; 2009 Jul; 43(7):1227-32. PubMed ID: 19584387
[TBL] [Abstract][Full Text] [Related]
47. The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
Pae CU; Lim HK; Peindl K; Ajwani N; Serretti A; Patkar AA; Lee C
Int Clin Psychopharmacol; 2008 Jan; 23(1):1-8. PubMed ID: 18090502
[TBL] [Abstract][Full Text] [Related]
48. Multicomponent behavioral treatment for chronic combat-related posttraumatic stress disorder: trauma management therapy.
Turner SM; Beidel DC; Frueh BC
Behav Modif; 2005 Jan; 29(1):39-69. PubMed ID: 15557478
[TBL] [Abstract][Full Text] [Related]
49. [Post-traumatic stress disorder with psychotic features].
Moskowits L; Bleich A
Harefuah; 1999 Oct; 137(7-8):281-3, 351. PubMed ID: 12415970
[TBL] [Abstract][Full Text] [Related]
50. New approaches in the pharmacotherapy of posttraumatic stress disorder.
Silver JM; Sandberg DP; Hales RE
J Clin Psychiatry; 1990 Oct; 51 Suppl():33-8; discussion 44-6. PubMed ID: 2120203
[TBL] [Abstract][Full Text] [Related]
51. [Impact of posttraumatic stress disorder symptoms and their intensity on patients working ability].
Anton S; Mandić N; Laufer D
Lijec Vjesn; 2004; 126(1-2):11-7. PubMed ID: 15526746
[TBL] [Abstract][Full Text] [Related]
52. Quetiapine therapy for posttraumatic stress disorder.
Sattar SP; Ucci B; Grant K; Bhatia SC; Petty F
Ann Pharmacother; 2002 Dec; 36(12):1875-8. PubMed ID: 12452747
[TBL] [Abstract][Full Text] [Related]
53. Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder.
Hamner MB; Frueh BC; Ulmer HG; Arana GW
Biol Psychiatry; 1999 Apr; 45(7):846-52. PubMed ID: 10202572
[TBL] [Abstract][Full Text] [Related]
54. Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans.
Lambert MT
Int Clin Psychopharmacol; 2006 May; 21(3):185-7. PubMed ID: 16528142
[TBL] [Abstract][Full Text] [Related]
55. Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study.
Carey P; Suliman S; Ganesan K; Seedat S; Stein DJ
Hum Psychopharmacol; 2012 Jul; 27(4):386-91. PubMed ID: 22730105
[TBL] [Abstract][Full Text] [Related]
56. Neopterin production in posttraumatic stress disorder before and after pharmacotherapy.
Atmaca M; Tezcan E; Kuloglu M; Onal S
Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):34-6. PubMed ID: 12664311
[TBL] [Abstract][Full Text] [Related]
57. Externalizing and internalizing subtypes of combat-related PTSD: a replication and extension using the PSY-5 scales.
Miller MW; Kaloupek DG; Dillon AL; Keane TM
J Abnorm Psychol; 2004 Nov; 113(4):636-45. PubMed ID: 15535795
[TBL] [Abstract][Full Text] [Related]
58. Risperidone in the treatment of acute stress disorder in physically traumatized in-patients.
Eidelman I; Seedat S; Stein DJ
Depress Anxiety; 2000; 11(4):187-8. PubMed ID: 10945142
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of psychotic comorbidity in combat-related post-traumatic stress disorder.
Kozarić-Kovacić D; Borovecki A
Mil Med; 2005 Mar; 170(3):223-6. PubMed ID: 15828699
[TBL] [Abstract][Full Text] [Related]
60. Posttraumatic stress disorder: clinical features, pathophysiology, and treatment.
Vieweg WV; Julius DA; Fernandez A; Beatty-Brooks M; Hettema JM; Pandurangi AK
Am J Med; 2006 May; 119(5):383-90. PubMed ID: 16651048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
